Verition Fund Management LLC Biogen Inc. Call Options Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $2.16 Million - $2.73 Million	10,200 Added 178.95%	15,900 $3.43 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $21.5 Million - $25.9 Million	-96,800 Reduced 94.44%	5,700 $1.47 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $26 Million - $29.3 Million	102,500 New	102,500 $26.3 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $19.5 Million - $26.8 Million	100,000 Added 500.0%	120,000 $32 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $1.94 Million - $2.44 Million	10,000 Added 100.0%	20,000 $4.21 Million
Q4 2021 May 03, 2022	BUY	$223.92 - $287.77 $2.24 Million - $2.88 Million	10,000 New	10,000 $2.4 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.